Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control study.
de Bloeme CM, Jansen RW, Cardoen L, Göricke S, van Elst S, Jessen JL, Ramasubramanian A, Skalet AH, Miller AK, Maeder P, Uner OE, Hubbard GB, Grossniklaus H, Boldt HC, Nichols KE, Brennan RC, Sen S, Koob M, Sirin S, Brisse HJ, Galluzzi P, Dommering CJ, Cysouw M, Boellaard R, Dorsman JC, Moll AC, de Jong MC, de Graaf P; European Retinoblastoma Imaging Collaboration.
de Bloeme CM, et al. Among authors: de graaf p.
Sci Rep. 2024 Oct 23;14(1):25103. doi: 10.1038/s41598-024-76933-6.
Sci Rep. 2024.
PMID: 39443629
Free PMC article.